Jan 3 A federal judge on Tuesday refused to
throw out a court verdict upholding two Amgen Inc
patents related to the company's cholesterol drug, a defeat for
Sanofi SA and Regeneron Pharmaceuticals Inc,
which make a rival drug.
In an October 2014 lawsuit, Amgen had sought to stop
Paris-based Sanofi and Tarrytown, New York-based Regeneron from
selling Praluent, a drug intended to lower bad LDL cholesterol
by blocking a protein known as PCSK9. A jury found Amgen's
patents valid in March.
(Reporting by Brendan Pierson in New York; Editing by Leslie